TY - JOUR
T1 - Efficacy of social cognition and interaction training in outpatients with schizophrenia spectrum disorders
T2 - randomized controlled trial
AU - Fiszdon, Joanna M.
AU - Dixon, H. Drew
AU - Davidson, Charlie A.
AU - Roberts, David L.
AU - Penn, David L.
AU - Bell, Morris D.
N1 - Publisher Copyright:
Copyright © 2023 Fiszdon, Dixon, Davidson, Roberts, Penn and Bell.
PY - 2023
Y1 - 2023
N2 - Given the relationship between social cognition and functional outcome in schizophrenia, a number of social cognitive interventions have been developed, including Social Cognition Interaction Training (SCIT), a group-based, comprehensive, manualized intervention. In the current trial, we examined SCIT efficacy as well as potential moderators of treatment effects. Fifty-one outpatients were randomized to SCIT or a wait-list-control (WLC), with assessments of social cognition, neurocognition, self-report, symptoms, and functioning conducted at baseline and end of the active phase. Relative to WLC, we did not find significant improvements for SCIT on neurocognition, social cognition, self-report, or symptoms, though there was a trend-level, medium effect favoring the SCIT condition on interpersonal and instrumental role function. Post-hoc analyses indicated that baseline neurocognition did not impact degree of social cognitive or functional change. Shorter duration of illness was significantly associated with better post-training neurocognition and self-esteem and, at trend-level with better symptoms and social functioning. We discuss the importance of outcome measure selection and the need for continued evaluation of potential treatment moderators in order to better match people to existing treatments. Clinical trial registration: Clinicaltrials.gov, Identifier NCT00587561.
AB - Given the relationship between social cognition and functional outcome in schizophrenia, a number of social cognitive interventions have been developed, including Social Cognition Interaction Training (SCIT), a group-based, comprehensive, manualized intervention. In the current trial, we examined SCIT efficacy as well as potential moderators of treatment effects. Fifty-one outpatients were randomized to SCIT or a wait-list-control (WLC), with assessments of social cognition, neurocognition, self-report, symptoms, and functioning conducted at baseline and end of the active phase. Relative to WLC, we did not find significant improvements for SCIT on neurocognition, social cognition, self-report, or symptoms, though there was a trend-level, medium effect favoring the SCIT condition on interpersonal and instrumental role function. Post-hoc analyses indicated that baseline neurocognition did not impact degree of social cognitive or functional change. Shorter duration of illness was significantly associated with better post-training neurocognition and self-esteem and, at trend-level with better symptoms and social functioning. We discuss the importance of outcome measure selection and the need for continued evaluation of potential treatment moderators in order to better match people to existing treatments. Clinical trial registration: Clinicaltrials.gov, Identifier NCT00587561.
KW - psychosis
KW - randomized controlled trial
KW - rehabilitation
KW - schizophrenia
KW - social cognition
KW - training
UR - http://www.scopus.com/inward/record.url?scp=85168373956&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85168373956&partnerID=8YFLogxK
U2 - 10.3389/fpsyt.2023.1217735
DO - 10.3389/fpsyt.2023.1217735
M3 - Article
C2 - 37599886
AN - SCOPUS:85168373956
SN - 1664-0640
VL - 14
JO - Frontiers in Psychiatry
JF - Frontiers in Psychiatry
M1 - 1217735
ER -